386 related articles for article (PubMed ID: 25650659)
1. Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression.
Valenti F; Ganci F; Fontemaggi G; Sacconi A; Strano S; Blandino G; Di Agostino S
Oncotarget; 2015 Mar; 6(8):5547-66. PubMed ID: 25650659
[TBL] [Abstract][Full Text] [Related]
2. The miR-205-5p/BRCA1/RAD17 Axis Promotes Genomic Instability in Head and Neck Squamous Cell Carcinomas.
Valenti F; Sacconi A; Ganci F; Grasso G; Strano S; Blandino G; Di Agostino S
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31514456
[TBL] [Abstract][Full Text] [Related]
3. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair.
Hartman AR; Ford JM
Nat Genet; 2002 Sep; 32(1):180-4. PubMed ID: 12195423
[TBL] [Abstract][Full Text] [Related]
5. BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations.
Holstege H; Horlings HM; Velds A; Langerød A; Børresen-Dale AL; van de Vijver MJ; Nederlof PM; Jonkers J
BMC Cancer; 2010 Nov; 10():654. PubMed ID: 21118481
[TBL] [Abstract][Full Text] [Related]
6. Antisense inhibition of BRCA1 expression and molecular analysis of hereditary tumors indicate that functional inactivation of the p53 DNA damage response pathway is required for BRCA-associated tumorigenesis.
Reedy MB; Hang T; Gallion H; Arnold S; Smith SA
Gynecol Oncol; 2001 Jun; 81(3):441-6. PubMed ID: 11371136
[TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas.
Yoshikawa K; Ogawa T; Baer R; Hemmi H; Honda K; Yamauchi A; Inamoto T; Ko K; Yazumi S; Motoda H; Kodama H; Noguchi S; Gazdar AF; Yamaoka Y; Takahashi R
Int J Cancer; 2000 Oct; 88(1):28-36. PubMed ID: 10962436
[TBL] [Abstract][Full Text] [Related]
8. Repression of new p53 targets revealed by ChIP on chip experiments.
Ceribelli M; Alcalay M; Viganò MA; Mantovani R
Cell Cycle; 2006 May; 5(10):1102-10. PubMed ID: 16721047
[TBL] [Abstract][Full Text] [Related]
9. Repression of BRCA1 through a feedback loop involving p53.
MacLachlan TK; Dash BC; Dicker DT; El-Deiry WS
J Biol Chem; 2000 Oct; 275(41):31869-75. PubMed ID: 10884389
[TBL] [Abstract][Full Text] [Related]
10. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability.
Buckley NE; D'Costa Z; Kaminska M; Mullan PB
Cell Death Dis; 2014 Feb; 5(2):e1070. PubMed ID: 24556685
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors.
Sourvinos G; Spandidos DA
Biochem Biophys Res Commun; 1998 Apr; 245(1):75-80. PubMed ID: 9535786
[TBL] [Abstract][Full Text] [Related]
13. Differing effects of breast cancer 1, early onset (BRCA1) and ataxia-telangiectasia mutated (ATM) mutations on cellular responses to ionizing radiation.
Mamon HJ; Dahlberg W; Azzam EI; Nagasawa H; Muto MG; Little JB
Int J Radiat Biol; 2003 Oct; 79(10):817-29. PubMed ID: 14630541
[TBL] [Abstract][Full Text] [Related]
14. Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival.
Weigman VJ; Chao HH; Shabalin AA; He X; Parker JS; Nordgard SH; Grushko T; Huo D; Nwachukwu C; Nobel A; Kristensen VN; Børresen-Dale AL; Olopade OI; Perou CM
Breast Cancer Res Treat; 2012 Jun; 133(3):865-80. PubMed ID: 22048815
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 controls BRCA1 gene expression and cellular localization in human breast cancer cells.
Glait C; Ravid D; Lee SW; Liscovitch M; Werner H
FEBS Lett; 2006 Oct; 580(22):5268-74. PubMed ID: 16979166
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor p53 is required to modulate BRCA1 expression.
Arizti P; Fang L; Park I; Yin Y; Solomon E; Ouchi T; Aaronson SA; Lee SW
Mol Cell Biol; 2000 Oct; 20(20):7450-9. PubMed ID: 11003642
[TBL] [Abstract][Full Text] [Related]
17. TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.
Greenblatt MS; Chappuis PO; Bond JP; Hamel N; Foulkes WD
Cancer Res; 2001 May; 61(10):4092-7. PubMed ID: 11358831
[TBL] [Abstract][Full Text] [Related]
18. In vitro analysis of genomic instability triggered by BRCA1 missense mutations.
Quaresima B; Faniello MC; Baudi F; Crugliano T; Cuda G; Costanzo F; Venuta S
Hum Mutat; 2006 Jul; 27(7):715. PubMed ID: 16786532
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: correlation with related protein products and morphologic features.
Otis CN; Krebs PA; Albuquerque A; Quezado MM; San Juan X; Sobel ME; Merino MJ
Int J Surg Pathol; 2002 Oct; 10(4):237-45. PubMed ID: 12490973
[TBL] [Abstract][Full Text] [Related]
20. The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer.
Coaxum SD; Tiedeken J; Garrett-Mayer E; Myers J; Rosenzweig SA; Neskey DM
Oncotarget; 2017 Apr; 8(14):22991-23007. PubMed ID: 28160562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
